<html>
<head>PUBMED IDs for AP1S2</head>
<body bgcolor='#C5F0F2'><h1>AP1S2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17186471/'>Mutations in the gene encoding the Sigma 2 subunit of the adaptor protein 1 complex, AP1S2, cause X-linked mental retardation.</a> December 23  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17617514/'>Mutations in the AP1S2 gene encoding the sigma 2 subunit of the adaptor protein 1 complex are associated with syndromic X-linked mental retardation with hydrocephalus and calcifications in basal ganglia.</a> July 10  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17617513/'>Mutation analysis of NPHP6/CEP290 in patients with Joubert syndrome and Senior-LÃ¸ken syndrome.</a> July 10  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18428203/'>Clinical, cellular, and neuropathological consequences of AP1S2 mutations: further delineation of a recognizable X-linked mental retardation syndrome.</a> April 23  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20358600/'>Clinical and molecular characterization of overlapping interstitial Xp21-p22 duplications in two unrelated individuals.</a> July 9  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21685710/'>Disease-dependent differently methylated regions (D-DMRs) of DNA are enriched on the X chromosome in uterine leiomyoma.</a> March 6  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22210230/'>Deletion of the AP1S2 gene in a child with psychomotor delay and hypotonia.</a> September 29  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23756445/'>AP1S2 is mutated in X-linked Dandy-Walker malformation with intellectual disability, basal ganglia disease and seizures (Pettigrew syndrome).</a> October 8  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24039954/'>New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion.</a> June 8  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25649377/'>Next-generation sequencing in X-linked intellectual disability.</a> May 7  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25649370/'>Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors.</a> August 26  2015<br></body></html>
